Acute Porphyria Drugs

S03BA01 - Dexamethasone

Not porphyrinogenic
NP

Rationale
Probably no significant systemic exposure. Several references: use/safe/authorised.
Chemical description
Glucocorticoid in solution 1mg/mL for ophtalmic and othologic use. South African list: use French list: authorized Kalman, Bonkowski: safe Tschudy DP, Lamon JM: Porphyrin metabolism and the porphyrias in Bondy PK, RosenbergLE (eds.): Duncan s Disease of metabolism. Philadelphia, WB Saunders,1980, p 939: safe Moore MR, Hift RJ: Drugs in the acute porphyrias. Cell Mol Biol 43:89, 1997 : safe
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes S03B / S03BA or go back.
References
# Citation details PubMed ID
1. Management of acute attacks in the porphyrias.
Kalman DR, Bonkovsky HL. Clin Dermatol. 1998; 16(2):299-306.
9554242
2. Drugs in the acute porphyrias--toxicogenetic diseases.
Moore MR, Hift RJ. Cell Mol Biol (Noisy-le-grand). 1997 Feb; 43(1):89-94.
9074793
Other sources
3. Porphyrin metabolism and the Porphyrias [Book Chapter]
Tschudy DP, Lamon JM Bondy BK, Rosenberg LE (eds): Duncan's Diseases of Metabolism, Philadelphia, WB Saunders. 1980.
Tradenames

Dexavision Dexamethasone Dexamethason
In cooperation with Ipnet
© Napos 2026
An unhandled error has occurred. Reload 🗙